You are here

Dermavant

Roivant’s magic trick: Finding the ‘weird-shaped’ pieces around Big Pharma’s cookie cutters

Pharma Voice

Thu, 09/26/24 - 11:00 am

Organon pays up to $1.2B to acquire Dermavant and its steroid-free skin cream Vtama

Fierce Pharma

Wed, 09/18/24 - 01:39 pm

immuno-dermatology

Dermavant CEO draws Botox comparison to instill Vtama confidence amid slow psoriasis uptake

Fierce Pharma

Tue, 11/28/23 - 11:29 pm

With new PhIII data in hand, Dermavant lines up topical psoriasis contender for a sprint to the finish line

Endpoints

Fri, 04/23/21 - 11:09 am

clinical trials

Phase 3 wins put Dermavant closer to filing Otezla rival tapinarof

Pharmaforum

Thu, 08/27/20 - 11:04 am

clinical trials

Ramaswamy's Dermavant Updates $124 Million IPO Filing

CP Wire

Mon, 06/10/19 - 09:53 am

Vivek Ramaswamy

Ramaswamy's Dermavant Updates $124 Million IPO Filing

Mon, 06/10/19 - 09:46 am

New IPO filings include BridgeBio, Dermavant, Prevail, Atreca, Akero

BioCentury

Mon, 05/27/19 - 11:42 pm

Prevail Therapeutics

Akero Therapeutics

Dermavant inks $330M deal for GSK's phase 3-ready psoriasis drug

Fierce Biotech

Thu, 07/12/18 - 06:17 pm

atopic dermatitis